Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Express Scripts
Deloitte
Julphar
UBS
Queensland Health
US Department of Justice
Chubb

Generated: June 23, 2018

DrugPatentWatch Database Preview

GENTAMICIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Gentamicin, and when can generic versions of Gentamicin launch?

Gentamicin is a drug marketed by Intl Medication, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Perrigo New York, Pharmaderm, Taro, Abbott, Fresenius Kabi Usa, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Akorn, Perrigo Co Tennessee, Alcon Pharms Ltd, Bausch And Lomb, Paco, Sandoz Inc, B Braun, and Baxter Hlthcare. and is included in thirty-eight NDAs.

The generic ingredient in GENTAMICIN is gentamicin sulfate. There are fifteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
Summary for GENTAMICIN
Drug patent expirations by year for GENTAMICIN

US Patents and Regulatory Information for GENTAMICIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062373-003 Sep 7, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms GENTAMICIN SULFATE gentamicin sulfate OINTMENT;TOPICAL 062496-001 Mar 14, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 063106-002 Nov 21, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062588-005 Jan 6, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Queensland Health
US Department of Justice
Daiichi Sankyo
Colorcon
McKesson
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.